A recent analysis from REasons for Geographic and Racial Differences in Stroke (REGARDS) found that AFib independently predicted dementia. In particular, it finds a much stronger connection to cognitive decline for people younger than 70 years of age. Our research indicates that younger AFib participants who are diagnosed with the condition experience an increased risk of developing dementia by 21%. This risk increases to 36% for those with early-onset dementia.
Atrial fibrillation, or arrythmia, which makes the heart beat irregularly, is present in about 3.25% of the study population. These results uncover a robust association between AFib and incident dementia in young adults. Yet this correlation disappears almost entirely for those above the age of 70. This trend further highlights the need for early diagnosis and intervention among patients diagnosed with AFib prior to attaining advanced age.
Dr. Drury, a key researcher involved in the study, noted that “there does however [appear to] be a much stronger association with dementia the earlier a person is diagnosed with AFib, which implies that AFib has potential mechanisms that can lead to dementia.” Younger patients may be at greater risk of cognitive decline associated with atrial fibrillation. This is a reflection of some recent data.
The new study highlights that while AFib continues to be a problem for older adults, its predictive power starts to fade in this age group. “Interestingly, the effect of atrial fibrillation on the risk for dementia diminishes in those older than 70 years old,” Dr. Drury said. He explained that several previous studies have found patients with AFib at a higher risk for dementia. This finding further underscores the need for more research in this highly urgent area.
The exact mechanisms through which AFib leads to dementia are still not well outlined. Dr. Drury emphasized the necessity for future research to explore how AFib induces changes in brain structure, such as brain atrophy or microinfarcts. He called for more research in understanding the mechanisms of how atrial fibrillation contributes to dementia. This is particularly important for gauging its effects on younger people.
Additionally, the study indicates that treatments for atrial fibrillation, including rhythm control strategies and anticoagulation therapy, may help mitigate cognitive decline. Rodriguez-Garcia noted that more research is necessary to understand the effectiveness of rhythm control strategies. These strategies, in tandem with other treatments for atrial fibrillation, can have a major positive impact on cognitive decline in our patients.
Dr. Drury cautioned that the study’s retrospective design restricts the conclusions that can be made. This is largely because it is unable to control for the exact treatments patients were given or what other health conditions they had. He explained that the study presents some surprising results. It is retrospective and does not go on to specify which exact treatments the patients received or other possible comorbidities.
These results emphasize the importance of early screening for cognitive impairment among patients with newly diagnosed AFib who are younger than 70. Early intervention has the potential to improve these patients tremendously. Dr. Drury emphasized the need to improve management of cardiovascular health overall to avoid allowing an AFib condition to develop. In fact, he said, focusing on those areas can significantly reduce the risk of cognitive decline in older adulthood.
Leave a Reply